Adar1 Capital Management, LLC Relmada Therapeutics, Inc. Transaction History

Adar1 Capital Management, LLC

  • $615 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$2.93 - $4.94 $146,500 - $247,000
50,000 Added 8319.47%
50,601 $152 Million
Q1 2024

May 15, 2024
SELL
$3.1 - $6.8 $179,800 - $394,400
-58,000 Reduced 98.97%
601 $2.8 Million
Q4 2023

Feb 14, 2024
BUY
$2.45 - $4.22 $143,572 - $247,296
58,601 New
58,601 $243 Million

Others Institutions Holding RLMD

# of Institutions
81
Shares Held
12.3M
Call Options Held
229K
Put Options Held
138K
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email